CeloNova
Introducing the world's first and only non drug-eluting, nanocoated coronary stent that allows physicians to treat patients with short, 1-month DAPT.
CeloNova Offices
OnSite Workspace
Employees work from physical offices.
Typical time on-site:
San Antonio, Texas, USA
